PF610 OUTCOMES FOR TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA RECEIVING LENALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE, OR BORTEZOMIB AND DEXAMETHASONE: AN ENHANCED DATABASE ANALYSIS

Authors: A. Chari, B. Ung, M. Tian, A. Agarwal, K. Parikh

Published: 2019-06-17

DOI: 10.1097/01.hs9.0000560728.38730.ae

Source: Full article

---

Abstract

No abstract found.